Exousia Pro Amends Offering, Seeks $1.5M at Premium Price Amidst Going Concern Doubts

summarizeSummary

Exousia Pro, Inc. filed an amendment to its Regulation A offering, increasing the shares offered by the company to 50 million at $0.03 per share, aiming to raise up to $1.5 million for operations, while also allowing selling shareholders to offer 15 million shares.

check_boxKey Events

• Expanded Capital Raise

  Exousia Pro increased its Regulation A offering to 50 million shares, targeting up to $1.5 million in proceeds for critical operations.

• Premium Offering Price

  Shares are priced at $0.03, a premium to the current market price of $0.02162, indicating some investor confidence despite the company's financial state.

• Significant Shareholder Dilution

  The offering, combined with selling shareholder sales, could increase outstanding shares by over 139%, with additional future dilution from 47 million Series B convertible shares.

• Going Concern Warning

  The company explicitly states "substantial doubt about its ability to continue as a viable business," making this capital raise essential for survival.

auto_awesomeAnalysis

This amended Regulation A offering is a critical financing event for Exousia Pro, which explicitly acknowledges "substantial doubt about its ability to continue as a viable business." The company is seeking to raise up to $1.5 million by offering 50 million shares at $0.03 each, a premium to its current market price of $0.02162. While raising capital at a premium is a positive signal, the sheer scale of the offering, which could increase outstanding shares by over 139%, represents significant dilution for existing shareholders. Furthermore, selling shareholders are offering an additional 15 million shares, from which the company will not benefit financially. The proceeds for the company are allocated to essential R&D and working capital. Investors should note the company's disclosure that Series B Convertible Preferred Stock convertible into 47 million shares remains outstanding and is a source of future dilution, which directly contradicts a recent news report of their cancellation.